RxDoctor Payments Data

Paul Morrissey, MD

Surgery · Providence, RINPI 1134101850

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,264 of the $1,407 with a category attached, or 89.8%. 8 manufacturers reported payments, led by Veloxis Pharmaceuticals, Inc. at 37.9% of the total.

$1,407in general payments, 2019–2025

Across 16 payments — averaging $87.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Veloxis Pharmaceuticals, Inc.$534
  • Calliditas Therapeutics US Inc.$231
  • Sanofi-aventis U.S. LLC$201
  • Vantive US Healthcare LLC$116
  • Amgen$104
  • E.r. Squibb & Sons, L.L.C.$101
  • plus $120 from 2 others

What the payments were for

  • Food & beverage$1,26490%
  • Education$14310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,407 in reported general payments places this provider in the 55th percentile of 108 surgery providers in Rhode Island.

See all surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$79,105
Medicare patients
152
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$11,999
Mycophenolic AcidMycophenolate Sodium30$11,959
Valganciclovir Hcl36$7,987
Tacrolimus26$5,649
Prednisone313$1,196
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim196$1,119
Pantoprazole Sodium171$948
Famotidine73$674
Nystatin21$591
Amlodipine Besylate98$586
Calcitriol13$312
Atorvastatin Calcium42$307
Labetalol Hcl11$301
Nifedipine ErNifedipine15$274
Levetiracetam12$104

Paid to pharmacies, not to this prescriber.

Other surgery in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →